8,517 articles
Paul O’Connor
Paul W. O'Connor is a Canadian neurologist and clinical epidemiologist who led pivotal multiple sclerosis trials, including the 2003 natalizumab and 2011 TEMSO teriflunomide trials.
Paul Owren
Paul Arnor Owren (1905–1990) was a Norwegian physician and professor at the University of Oslo who discovered coagulation Factor V and developed the Thrombotest method.
Paul P. Carbone
Paul P. Carbone was an American medical oncologist who helped develop MOPP and CMF chemotherapy, led ECOG, shared the 1972 Lasker Award, and directed the UW Comprehensive Cancer Center.
Paul Quinton
Paul M. Quinton is an American physiologist at the University of California who defined the basic electrolyte defect in cystic fibrosis through experiments on single human sweat ducts.
Paul Robert Bing
Paul Robert Bing (1878–1956) was a German-Swiss neurologist who founded modern neurology in Basel, wrote influential neurology textbooks, and gave his name to Bing's reflex and the Bing-Horton syndrome.
Paul Roberts Cannon
Paul Roberts Cannon (1892–1986) was an American pathologist and immunologist at the University of Chicago who showed that dietary protein is required to maintain resistance to infection.
Paul Rutgeerts
Paul Rutgeerts (1948–2020) was a Belgian gastroenterologist and professor at KU Leuven whose infliximab trials reshaped IBD treatment, and whose Rutgeerts score and SES-CD remain standard in Crohn's disease trials.
Paul S. Appelbaum
Paul S. Appelbaum is an American psychiatrist at Columbia University who works at the intersection of law, ethics, and psychiatry, known for the MacCAT-T capacity assessment tool.
Paul S. Chan
Paul S. Chan is an American cardiologist at Saint Luke's Mid America Heart Institute in Kansas City who studies cardiac arrest outcomes and care quality.
Paul S. Frenette
Paul S. Frenette (1965–2021) was a Canadian hematologist and stem cell biologist who founded and led the Gottesman Institute for Stem Cell Research at Albert Einstein College of Medicine.
Paul S. Lietman
Paul S. Lietman (1934–2013) was a clinical pharmacologist who directed the Division of Clinical Pharmacology at Johns Hopkins and studied aminoglycoside antibiotics, acyclovir, and HIV drugs.
Paul S. Myles
Paul S. Myles is an Australian anaesthesiologist and clinical trialist who heads anaesthesiology at Alfred Health and Monash University, elected to the US National Academy of Medicine in 2019.
Paul S. Russell
Paul S. Russell (1925–2026) was an American transplant surgeon and immunologist who spent seven decades at Massachusetts General Hospital and Harvard, helping establish organ transplantation as a clinical treatment.
Paul Sandifer
Paul Harmer Sandifer (1908–1964) was a British neurologist remembered as the pioneer of British pediatric neurology and for Sandifer syndrome, a reflux-related dystonia of childhood.
Paul Spiegel
Paul B. Spiegel is a Canadian physician and medical epidemiologist who directs the Johns Hopkins Center for Humanitarian Health and is known for research on refugee and displacement health.
Paul Sudeck
Paul Hermann Martin Sudeck was a German surgeon in Hamburg who in 1900 first described acute bone atrophy after limb trauma, known as Sudeck's atrophy.
Paul T. Schumacker
Paul T. Schumacker, also known as Paul Schumacker, is a scientist at Northwestern University Feinberg School of Medicine known for the mitochondrial ROS hypothesis of oxygen sensing.
Paul Talalay
Paul Talalay (1923–2019) was an American pharmacologist at Johns Hopkins who founded the field of chemoprotection and identified sulforaphane from broccoli as a potent inducer of detoxification enzymes.
Paul Trendelenburg
Paul Trendelenburg (1884–1931) was a German pharmacologist and physician who held chairs of pharmacology at Rostock, Freiburg, and Berlin, and whose 1917 guinea-pig ileum method remains in laboratory use.
Paul Uhlenhuth
Paul Uhlenhuth (1870–1957) was a German bacteriologist and immunologist who developed the precipitin test for distinguishing human from animal blood, the first reliable forensic species test, and later contributed to arsenical chemotherapy for syphilis.
Paul Vaska
Paul Vaska is an American PET physicist at Brookhaven National Laboratory and professor at Stony Brook University, known for the RatCAP conscious-animal scanner and simultaneous PET/MRI.
Paul W. Armstrong
Paul W. Armstrong is a Canadian cardiologist at the University of Alberta who led major acute cardiac care trials and was appointed an Officer of the Order of Canada in 2017.
Paul W. Franks
Paul W. Franks (born 1973 in Stockport, England) is a professor of genetic epidemiology at Lund University, known for research on the genetics of obesity and type 2 diabetes.
Paul W. Kincade
Paul W. Kincade (1944–2025) was an American immunologist at the Oklahoma Medical Research Foundation known for work on B cell development, and a president of the American Association of Immunologists.
Paul W. Newacheck
Paul W. Newacheck is an American health policy researcher and Professor Emeritus at the University of California, San Francisco, known for studies of children's health insurance.
Paul W. Noble
Paul W. Noble is an American pulmonary physician-scientist who studies lung fibrosis, led divisions at Duke and Cedars-Sinai, and is now a Clinical Professor at UNC Chapel Hill.
Paul W.H.I. Parren
Paul W.H.I. Parren is a Dutch molecular immunologist, Professor of Immunology at Leiden University Medical Center since 2015, and an inventor of six approved therapeutic antibodies including daratumumab.
Paul Wilkinson (epidemiologist)
Paul Wilkinson was a British environmental epidemiologist and professor at the London School of Hygiene & Tropical Medicine who researched climate change and air pollution.
Paul Workman (cancer pharmacologist)
Paul Workman is a cancer pharmacologist and chemical biologist at the Institute of Cancer Research, London, known for kinase and Hsp90 inhibitors and the Pharmacological Audit Trail.
Paul Y. Kwo
Paul Y. Kwo is an American transplant hepatologist and Professor of Medicine at Stanford, known as principal investigator for trials establishing direct-acting antiviral therapy for hepatitis C.